Background
CMV viremia is strongly associated with increased mortality in persons with advanced HIV disease, particularly those with cryptococcal meningitis. It is unclear if CMV viremia is driving HIV-associated mortality, or if CMV serves as a sensitive biomarker of HIV-related immune dysfunction. We hypothesized that the upregulation of anti-inflammatory cytokines may provide a mechanistic explanation for the decreased survival observed in CMV and cryptococcal meningitis co-infection.
Methods
We measured human plasma IL-10 levels by Luminex assay and measured CMV viral IL-10 homolog using ELISA in the plasma of 91 Ugandans with cryptococcal meningitis. Simple imputation was used to standardize values below or above assay limits of quantification. We then quantified plasma CMV DNA concentrations by PCR. Univariate logistic regression examined the odds of each log2-transformed cytokine being associated with CMV viremia. Univariate Cox regression determined association with 2-week mortality. No covariate adjustment or correction for multiple comparisons were made for this preliminary analysis.
Results
The 91 participants had a median age of 35 years (IQR, 30–42) and were 57% male (52/91). The median CD4 count was 28 cells/mL (IQR, 11–75) and 23% (21/91) were receiving ART at baseline. A total of 25% (23/91) had CMV viremia, with a median CMV viral load of 569 IU/mL (IQR, 135–36,300). Persons with CMV viremia had higher median concentrations of human IL-10 (70 pg/mL [IQR, 31–238] vs. 40 pg/mL [IQR, 16–85]; Odds Ratio=1.51; 95%CI, 1.12–2.11; p=.010) and lower concentrations of viral IL-10 (0 pg/mL [IQR, 0.0–1.35] vs. 0.4 pg/mL [0.0–9.7]; Odds Ratio=0.73; 95%CI, 0.52–0.05; p=.036) compared to those without CMV viremia. Overall mortality at 2-weeks for the cohort was 14% (13/91). Human plasma IL-10 was significantly associated with 2-week mortality (Hazard Ratio=1.44; 95%CI, 1.05–1.99; p=.024). Mortality increased dramatically in those within the highest tertile of human IL-10 production (Fig.1). CMV viral IL-10 was not associated with mortality.
Conclusions
Baseline CMV viremia was associated with increased concentrations of human IL-10, and decreased concentrations of CMV viral IL-10 in this predominantly ART naive cohort. Only human IL-10 was associated with 2-week mortality. These preliminary data suggest immune modulation via upregulation of human IL-10 may be a reason for worse outcomes in persons with HIV with CMV viremia and Cryptococcus co-infection.
Table or Figure